Company profile
Instrumentation for clinical, biotechnology, food and environment
Haemaflow was established in 2008 to develop spin-out inventions arising from the Haemair work on supporting people with lung disease or lung damage.
Updated 06 Jun 2026 16:52
Financial period: 1 Jun 2024 to 31 May 2025
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
CS01 | Transaction MzUyMzg2MzQ2MGFkaXF6a2N4
Published 27 May 2026 09:10
Last confirmation statement made up date
Last accounts made up date
AA | Transaction MzQzODU1MzA5OWFkaXF6a2N4
Published 07 Oct 2024 08:16
Company registered at Companies House
1 Nov 2012 to 30 Nov 2013
Donated blood deteriorates in storage so that it no longer carries oxygen efficiently. After transfusion, it can take 48 hrs to become fully reactivated.Donated blood may initially reduce the oxygen-carrying efficiency of thepatient’s own blood. The longer the blood is stored, the greater the risk. Our objective is to investigate a technology that promise...
